These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28360205)

  • 1. Simulation of Tracer Dose Reduction in
    Seith F; Schmidt H; Kunz J; Küstner T; Gatidis S; Nikolaou K; la Fougère C; Schwenzer N
    J Nucl Med; 2017 Oct; 58(10):1699-1705. PubMed ID: 28360205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining optimal tracer activities in pediatric oncologic whole-body
    Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF; Schäfer JF
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of image metrics for reduced and standard dose pediatric
    Zucchetta P; Branchini M; Zorz A; Bodanza V; Cecchin D; Paiusco M; Bui F
    Br J Radiol; 2019 Mar; 92(1095):20180438. PubMed ID: 30673306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of
    Sah BR; Ghafoor S; Burger IA; Ter Voert EEGW; Sekine T; Delso G; Huellner M; Dedes KJ; Boss A; Veit-Haibach P
    J Nucl Med; 2018 Dec; 59(12):1817-1822. PubMed ID: 29880506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients.
    Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Wetter A; Umutlu L; Antoch G; Heusch P
    J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative and visual analyses of the effect of activity reduction on image metrics and quality in 18F-FDG PET/MRI in pediatric oncology.
    Aydos U; Balcı E; Ateş SG; Akdemir ÜÖ; Karadeniz C; Atay LÖ
    Turk J Med Sci; 2023 Feb; 53(1):289-302. PubMed ID: 36945939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.
    Everaert H; Vanhove C; Lahoutte T; Muylle K; Caveliers V; Bossuyt A; Franken PR
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1615-9. PubMed ID: 14504831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
    Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S
    Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body PET/CT studies with lowered ¹⁸F-FDG doses: the influence of body mass index in dose reduction.
    Sánchez-Jurado R; Devis M; Sanz R; Aguilar JE; del Puig Cózar M; Ferrer-Rebolleda J
    J Nucl Med Technol; 2014 Mar; 42(1):62-7. PubMed ID: 24503348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose Reduction in Pediatric Oncology Patients with Delayed Total-Body [
    Mingels C; Spencer BA; Nalbant H; Omidvari N; Rokni M; Rominger A; Sen F; Cherry SR; Badawi RD; Abdelhafez YG; Nardo L
    J Nucl Med; 2024 Jul; 65(7):1101-1106. PubMed ID: 38664017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient.
    Vogel J; Seith F; Estler A; Nikolaou K; Schmidt H; la Fougère C; Küstner T
    Tomography; 2023 Sep; 9(5):1799-1810. PubMed ID: 37888735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image quality and lesion detectability in low-dose pediatric
    Zhao YM; Li YH; Chen T; Zhang WG; Wang LH; Feng J; Li C; Zhang X; Fan W; Hu YY
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3378-3385. PubMed ID: 33738519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
    Alves VPV; Brady S; Ata NA; Li Y; MacLean J; Zhang B; Sharp SE; Trout AT
    AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of optimal acquisition duration or injected activity for pediatric 18F-FDG PET/CT.
    Alessio AM; Sammer M; Phillips GS; Manchanda V; Mohr BC; Parisi MT
    J Nucl Med; 2011 Jul; 52(7):1028-34. PubMed ID: 21680684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image Quality and Activity Optimization in Oncologic
    van Sluis J; Boellaard R; Dierckx RAJO; Stormezand GN; Glaudemans AWJM; Noordzij W
    J Nucl Med; 2020 May; 61(5):764-771. PubMed ID: 31628214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.